drugset
drugset / Trial / NCT04723589

Restoration of Endothelial Integrity in Patients With COVID-19 (RELIC)

NCT04723589 ↗

Phase 2 Withdrawn University of Alabama at Birmingham
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a pilot study designed to demonstrate the feasibility of conducting a larger study of standard plasma therapy in COVID-19 patients.

Timeline

Start
2021-04-30
Primary completion
2021-04-30
Completion
2021-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Plasma Other / unclassified — —

Indications

COVID-19